DAC Accession Contact Person Email Access Information
EGAC00000000011 Sarah_Jane Lee TDOadmin@phsa.ca http://www.ebi.ac.uk/ega/dacs/EGAC00000000011

This DAC controls 359 datasets:

Dataset Accessionsort ascending Technology Samples Description
EGAD00010000658 0 DLBCL 148 SNP 6.0 Cohort
EGAD00010000504 Affymetrix_U133plus2- 35 Control samples using SNP Array 6.0
EGAD00010000502 Affymetrix_U133plus2- 35 Case samples using SNP Array 6.0
EGAD00010000500 Affymetrix_U133plus2- 35 Case samples using U133 Plus 2.0 Array
EGAD00010000148 Affymetrix_GenomeWide_SNP6.34 104 tumour samples using Affymetrix Genome-Wide SNP6.0 arrays
EGAD00001003422 Illumina HiSeq 2500;ILLUMINA 5 WXS from barcoded cells that are FACS sorted from GBM-719 xenografts, and the germline reference from patient GBM-719. The 4 xenografts are named according to passage (secondary or tertiary) and treatment (vehicle control or temozolomide).
EGAD00001003414 Illumina HiSeq 2500;ILLUMINA, NextSeq 500;ILLUMINA 40 June 2017 data update (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.
EGAD00001003293 Illumina HiSeq 2500;ILLUMINA 11 RNA-Seq and WXS from 6 glioblastoma patients
EGAD00001003272 Illumina HiSeq 2500;ILLUMINA 8 March 2017 data update (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.
EGAD00001003125 224 WGS data of medulloblastoma tumor/control pairs.
EGAD00001003122 Illumina HiSeq 2500;ILLUMINA 5 December 2016 data update (bam/fastq for WGBS on samples CEMT0062, CEMT0068, CEMT0072, CEMT0086, CEMT0087) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.
EGAD00001003091 2 Genome and transcriptome sequence data from a clear cell carcinoma of ovary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study
EGAD00001003090 2 Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study
EGAD00001003089 2 Genome and transcriptome sequence data from a pancreatic neuroendocrine patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study
EGAD00001003088 2 Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

Pages

DAC description

Access to data generated by BCCA is made available by completing the data access agreement for review by the data access committee and will be granted to qualified investigators for appropriate use.